Dr. Ashley Nicole Lowery, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1637 Us Highway 74a Byp, Spindale, NC 28160 Phone: 828-275-0050 |
Dr. Spencer Leon Lambert, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 136 Reservation Dr, Spindale, NC 28160 Phone: 828-286-2962 Fax: 828-286-3224 |
Dr. William Harold Thompson, DDS Dentist Medicare: Medicare Enrolled Practice Location: 202 E Main Street, Spindale, NC 28160 Phone: 828-286-4371 Fax: 828-286-4342 |
Dr. Charles C. Quarles, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 204 Reservation Dr, Spindale, NC 28160 Phone: 828-286-2962 |
Dr. John Selph, DMD Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1637 College Ave, Spindale, NC 28160 Phone: 828-375-0050 |
Dr. Michael Wayne Jackson, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 837 Thunder Rd, Spindale, NC 28160 Phone: 828-287-7592 Fax: 828-288-1293 |
Brian Caleb Bloem Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 136 Reservation Dr, Spindale, NC 28160 Phone: 828-286-2962 |
News Archive
Exiqon A/S, a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification.
In a major scientific study published in the journal Cell, scientists at the UNC School of Medicine and the UNC Gillings School of Global Public Health have characterized the specific ways in which SARS-CoV-2 – the coronavirus that causes COVID-19 – infects the nasal cavity to a great degree – replicating specific cell types – and infects and replicates progressively less well in cells lower down the respiratory tract, including the lungs.
The EU Joint Program - Neurodegenerative Disease Research initiative has launched its updated global Research and Innovation Strategy, to provide a unified framework for the support of world class research into neurodegenerative diseases.
Athersys, Inc. announced today that the U.S. Food and Drug Administration (FDA) has authorized commencement of a Phase II clinical trial evaluating the safety and efficacy of administration of MultiStem, Athersys' allogeneic investigational cell therapy product, for the potential treatment of ulcerative colitis.
George Berci, MD, FACS, FRCS, Ed. (Hon), a general surgeon from Los Angeles, CA, is the recipient of the 2011 Jacobson Innovation Award of the American College of Surgeons.
› Verified 5 days ago